Southern Research collaborating to develop coronavirus vaccine
Birmingham-based Southern Research has entered into a strategic collaboration with New York-based clinical-stage biopharmaceutical company Tonix Pharmaceuticals to support the development of a vaccine against the new coronavirus disease, COVID-19.
The vaccine is based on Tonix’s proprietary horsepox vaccine platform, TNX-801. The vaccine has been developed as a potential smallpox preventing vaccine for the U.S. strategic national stockpile and as a vaccine against monkeypox.
According to Southern…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news
More News: Coronavirus | Health Management | Pharmaceuticals | Smallpox | Smallpox Vaccine | Vaccines